The Types segment disaggregates the market into three principal product families, each with distinct production pathways and end‑use implications. Natural bio‑fermented astaxanthin from Phaffia yeast accounts for the majority share, estimated at 60 %, owing to its superior bioavailability and consumer preference for clean‑label ingredients. Synthetic astaxanthin, produced via chemical synthesis, holds approximately 25 % of the market; it competes on cost but lacks the regulatory acceptance in nutraceutical and cosmetic applications that require natural sourcing. A smaller Hybrid category, comprising 15 % of sales, blends natural and synthetic fractions to balance price sensitivity with performance claims, often marketed as “partially natural.” Within the natural family, sub‑types such as free‑form, esterified, and xanthophyll‑rich variants further differentiate product positioning based on solubility and stability profiles. This type‑based taxonomy clarifies how production technology and formulation requirements drive revenue allocation across the Phaffia Yeast Astaxanthin market.